Label: KETOROLAC TROMETHAMINE solution
- NDC Code(s): 72189-335-05
- Packager: Direct Rx
- This is a repackaged label.
- Source NDC Code(s): 42571-137
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated March 7, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
INDICATIONS & USAGE
Before you use Ketorolac Tromethamine Ophthalmic solution 0.5% for the first time:
1.Check to make sure that the tamper evident ring between the bottle and the cap is not broken ( See Figure A). If the tamper evident ring is broken or missing, contact your pharmacist.
[Img-fig-a]
2.Tear off the tamper evident ring ( See Figure B).
[Img-fig-b]
3.To open the bottle, remove the cap by turning it in the counterclockwise direction ( See Figure C).
[Img-fig-c]
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Rev.10/2021
-
88436-1 - Section Title Not Found In Database
17.1 Slow or Delayed Healing
Patients should be informed of the possibility that slow or delayed healing may occur while using nonsteroidal anti-inflammatory drugs (NSAIDs).
17.2 Avoiding Contamination of the Product
Patients should be instructed to avoid allowing the tip of the bottle to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Also, to avoid the potential for cross-contamination, the patient should be advised to use one bottle for each eye following bilateral ocular surgery. The use of the same bottle of topical eye drops for both eyes following bilateral ocular surgery is not recommended.
17.3 Contact Lens Wear
Patients should be advised that ketorolac tromethamine ophthalmic solution 0.5% should not be administered while wearing contact lenses.
17.4 Intercurrent Ocular Conditions
Patients should be advised that if they develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery, they should immediately seek their physician’s advice concerning the continued use of ketorolac tromethamine ophthalmic solution 0.5%.
17.5 Concomitant Topical Ocular Therapy
Patients should be advised that if more than one topical ophthalmic medication is being used, the medicines should be administered at least 5 minutes apart.
Manufactured by:
Micro Labs Limited
Bangalore-560099, INDIA.
Manufactured for:
Micro Labs USA Inc.
Somerset, NJ 08873
Rev.10/2021
-
HOW SUPPLIED
Ketorolac Tromethamine Ophthalmic solution 0.5% is supplied sterile, in white opaque LDPE bottles with white opaque LDPE Nozzles with HDPE grey caps as follows.
3 mL in 5 mL bottle NDC 42571-137-31
5 mL in 5 mL bottle NDC 42571-137-25
10 mL in 10 mL bottle NDC 42571-137-26
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
-
CLINICAL STUDIES
Two controlled clinical studies showed that ketorolac tromethamine ophthalmic solution was significantly more effective than its vehicle in relieving ocular itching caused by seasonal allergic conjunctivitis.
Two controlled clinical studies showed that patients treated for two weeks with ketorolac tromethamine ophthalmic solution were less likely to have measurable signs of inflammation (cell and flare) than patients treated with its vehicle.
Results from clinical studies indicate that ketorolac tromethamine has no significant effect upon intraocular pressure; however, changes in intraocular pressure may occur following cataract surgery.
-
DESCRIPTION
Ketorolac tromethamine ophthalmic solution 0.5% is a member of the pyrrolo-pyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use. Its chemical name is (±)-5-Benzoyl-2,3-dihydro-1H pyrrolizine-1-carboxylic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) and it has the following structure:
Ketorolac tromethamine ophthalmic solution 0.5% is supplied as a sterile isotonic aqueous 0.5% solution, with a pH of 7.4. Ketorolac tromethamine ophthalmic solution 0.5% is a racemic mixture of R-(+) and S-(-)- ketorolac tromethamine. Ketorolac tromethamine may exist in three crystal forms. All forms are equally soluble in water. The pKa of ketorolac is 3.5. This white to off-white crystalline substance discolors on prolonged exposure to light. The molecular weight of ketorolac tromethamine is 376.41. The osmolality of ketorolac tromethamine ophthalmic solution 0.5% is 290 mOsmol/kg.
Each mL of ketorolac tromethamine ophthalmic solution contains: Active: ketorolac tromethamine 0.5%. Preservative: benzalkonium chloride 0.01%. Inactives: edetate disodium 0.1%; octoxynol 40; water for injection; sodium chloride; hydrochloric acid and/or sodium hydroxide to adjust the pH.
-
INDICATIONS & USAGE
Ketorolac tromethamine ophthalmic solution 0.5% is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. Ketorolac tromethamine ophthalmic solution 0.5% is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
KETOROLAC TROMETHAMINE
ketorolac tromethamine solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72189-335(NDC:42571-137) Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength KETOROLAC TROMETHAMINE (UNII: 4EVE5946BQ) (KETOROLAC - UNII:YZI5105V0L) KETOROLAC TROMETHAMINE 5 mg in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) SODIUM HYDROXIDE (UNII: 55X04QC32I) OCTOXYNOL-40 (UNII: 9T1C662FKS) HYDROCHLORIC ACID (UNII: QTT17582CB) EDETATE DISODIUM (UNII: 7FLD91C86K) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72189-335-05 5 mL in 1 BOTTLE; Type 0: Not a Combination Product 03/07/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA203410 03/07/2022 Labeler - Direct Rx (079254320) Registrant - Direct Rx (079254320) Establishment Name Address ID/FEI Business Operations Direct Rx 079254320 relabel(72189-335)